Industry-specific consulting for
Chemical and pharmaceutical industry
For more than 30 years TMG Consultants has been supporting chemical and pharmaceutical companies in their transformation – with a deep understanding of processes, cross-industry expertise and a clear focus on results
The chemical-pharmaceutical industry is a key area of key technologies with enormous economic significance. With an annual turnover of around 250 billion euros and almost 500,000 employees in Germany, the sector supplies essential primary products and innovative solutions for almost all industrial value chains. Germany is Europe’s largest chemical producer and a global exporter. Due to sustainability, innovation and market changes, the industry is undergoing a transformation that requires investment, the revision of business models and new technologies.
Industry in transition
What are the current challenges facing the chemical & pharmaceutical industry?
The chemical & pharmaceutical industry finds itself in a complex field of tension: energy and raw material prices remain high and volatile – particularly as a result of the geopolitical situation. At the same time, stricter environmental regulations (e.g. REACH, EU Green Deal, ESG regulation) are placing high demands on production and product design. The pressure to innovate due to biotechnology, digitalization and sustainability is enormous, while investments are increasingly migrating to non-European markets. In the pharmaceutical industry, regulatory requirements, rising development costs and increasing pressure on margins are hampering market dynamics.
Strategies for the future
What is the current need for adjustment and optimization?
Companies in the chemical and pharmaceutical industries must initiate comprehensive transformation processes in order to remain competitive in the future:
- Driving decarbonization and the circular economy:
The conversion of energy-intensive processes to green chemistry and CO₂-neutral production requires massive investment, open-technology approaches and cross-sector cooperation. - Realign research and development:
Innovation must be more strongly oriented towards market needs and sustainability goals – with shorter development cycles, a higher degree of digitalization (e.g. simulation, AI-supported drug development) and closer integration of laboratory and production. - Restructuring of production networks:
Global production and supply networks must be geared towards resilience, flexibility and ESG compliance. Location decisions are becoming more strategically important, particularly with regard to energy availability, political stability and the regulatory environment. - Strengthen cost and profit management:
Significant efficiency potential can be realized through automation, advanced analytics and lean programs, particularly in indirect areas, raw material procurement, plant operation and maintenance. - Scaling digital transformation:
From process automation to data-driven quality control to paperless production – digitalization is becoming the core component of a high-performance, compliance-secure and agile operating model.
Industry expertise
Selected reference customers in the chemical and pharmaceutical industry
Contactform
We Look Forward to Discussing Matters with You!
You are currently viewing a placeholder content from HubSpot. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More Information